Real-World Data Show Unmet Need in KRAS p.G12C-Mutated Metastatic Colorectal Cancer
Patients with KRAS p.G12C mutations had numerically shorter overall survival and progression-free survival.
Gastrointestinal Cancer Clinical Trials
High IDO1 Tumor Expression May Predict Poor Overall Survival in Patients With Anal Cancer
High tumor expression of IDO1 may identify whether a patient is likely to respond to immunotherapy, according to study authors.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Gastrointestinal Cancer Clinical Trials
Loading... 
Loading...